Get the Stockscreener App
11.45
1.55%
-0.19
Daxor Corporation stock is traded at $11.45, with a volume of 999.
It is down -1.55% in the last 24 hours and down -6.53% over the past month.
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
See More
Previous Close:
$11.64
Open:
$11.3627
24h Volume:
999
Relative Volume:
0.13
Market Cap:
$66.72M
Revenue:
$2.61M
Net Income/Loss:
$1.69M
P/E Ratio:
38.13
EPS:
0.3003
Net Cash Flow:
-
1W Performance:
-4.10%
1M Performance:
-6.53%
6M Performance:
+3.62%
1Y Performance:
+52.80%
1-Day Range:
$11.36
$11.68
1-Week Range:
$11.05
$12.25
52-Week Range:
$7.10
$14.76
Daxor Corporation Stock (DXR) Company Profile
Name
Daxor Corporation
Sector
Industry
Phone
212-330-8500
Address
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
11.45 | 67.83M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
491.14 | 177.98B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
169.60 | 48.78B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
82.31 | 41.08B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
251.15 | 37.74B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
43.84 | 34.80B | 28.43B | 1.16B | 1.26B | 1.4457 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-19 | Initiated | Ascendiant Capital Markets | Buy |
Daxor Corporation Stock (DXR) Latest News
DXR SEC FilingsDAXOR CORP 10-K, 10-Q, 8-K Forms - Stock Titan
Daxor Corporation Reports 2025 Fiscal Year Results, Operating Revenue Up 45%, Net Asset Value Rises to $9.07 per Share - marketscreener.com
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders - Bitget
Daxor reports 45% revenue growth, plans regulatory shift - Investing.com
Daxor Corporation CEO and President Michael Feldschuh provides corporate update in letter to shareholders - marketscreener.com
Daxor (DXR) Records Strong Growth and Regulatory Changes in 2025 - GuruFocus
Daxor issues update in Letter to Shareholders - TipRanks
Daxor (DXR) Secures FDA Clearance for Advanced Blood Volume Anal - GuruFocus
Daxor Corporation CEO And President Michael Feldschuh Provides Corporate Update In Letter To Shareholders - TradingView
7-pound blood volume analyzer wins FDA clearance, gains hospital users - Stock Titan
Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share - marketscreener.com
FDA clears faster blood volume test as Daxor revenue surges 45% - Stock Titan
DXR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
FDA‑cleared BVA boosts momentum; Daxor (NASDAQ: DXR) posts NAV $9.07 and $46M operating valuation - Stock Titan
Daxor Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Short Interest in Daxor Corporation (NASDAQ:DXR) Decreases By 44.0% - MarketBeat
Daxor Corporation (DXR) Competitors - Meyka
Daxor (NASDAQ:DXR) vs. Addus HomeCare (NASDAQ:ADUS) Financial Survey - Defense World
EBIT per share of Daxor Corporation – NASDAQ:DXR - TradingView
Daxor (NYSEAMERICAN:DXR) Share Price Crosses Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Daxor continues strategic expansion, opens new BVA program in Tennessee - TipRanks
Daxor (DXR) Expands BVA Program to Southern Middle Tennessee - GuruFocus
Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee - The Manila Times
Gainers Report: Will LightPath Technologies Inc benefit from government policy2025 Key Lessons & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Daxor (NYSEAMERICAN:DXR) Stock Crosses Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Is Daxor Corporation stock a safe haven assetWeekly Profit Summary & Stock Portfolio Risk Control - mfd.ru
Can Daxor Corporation stock double in next 5 yearsTrade Risk Report & Fast Entry and Exit Trade Plans - mfd.ru
Daxor to shift regulatory reporting from Investment Company Act By Investing.com - Investing.com South Africa
Winners Losers: Is Daxor Corporation a turnaround storyWeekly Earnings Recap & Reliable Price Breakout Alerts - baoquankhu1.vn
Daxor Corp reaffirms focus on blood volume analysis technology - marketscreener.com
Daxor Corp Reaffirms Focus On Blood Volume Analysis Technology - TradingView
Daxor to transition to Securities Exchange Act of 1934 reporting company - TipRanks
Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business - The Manila Times
Daxor Corporation Announces Transition To Securities - GlobeNewswire
Daxor (NYSEAMERICAN:DXR) Stock Passes Below 200 Day Moving AverageTime to Sell? - MarketBeat
Trading the Move, Not the Narrative: (DXR) Edition - Stock Traders Daily
Daxor (NASDAQ:DXR) Stock Price Up 0.6%Time to Buy? - MarketBeat
Contrasting Daxor (NASDAQ:DXR) and Quest Diagnostics (NYSE:DGX) - Defense World
Aug Swings: Should I invest in Daxor Corporation before earningsPortfolio Profit Report & Safe Entry Point Alerts - baoquankhu1.vn
Guidance Update: Is Daxor Corporation a turnaround storySwing Trade & Stock Timing and Entry Methods - baoquankhu1.vn
What is the PEG ratio of Daxor CorporationOil Prices & Safe Entry Momentum Stock Tips - mfd.ru
What are Daxor Corporation’s technical support levels2025 Growth vs Value & Accurate Intraday Trading Signals - mfd.ru
Aug Outlook: Will Daxor Corporation stock go up in YEAR2025 Buyback Activity & Real-Time Buy Zone Alerts - baoquankhu1.vn
Daxor completes $8.1 million direct offering of common stock on Nasdaq - Investing.com Australia
Daxor Signs Multiple Material Agreements - TradingView
Daxor Corporation Announces $9 Million Registered Direct Offering - Sahm
Daxor Releases Updated Investor Presentation to Public Markets - The Globe and Mail
Daxor prices 765,958 shares at $11.75 in registered direct offering - TipRanks
Daxor to raise $9M in new stock sale at $11.75 a share - Stock Titan
Why is Daxor Corporation stock going downAnalyst Downgrade & Capital Efficiency Focused Ideas - bollywoodhelpline.com
Price-Driven Insight from (DXR) for Rule-Based Strategy - Stock Traders Daily
Daxor Corporation Stock (DXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.32%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):